MSD (Merck) will acquire Terns Pharmaceuticals for approximately USD 6.7 billion, adding investigational leukemia therapy TERN 701 to its oncology pipeline.

The global immuno-oncology market is projected to grow at a robust CAGR of approximately 21% over the next five years. This strong expansion is fueled by the rising global cancer burden, continuous ...

IntroductionThe global herbal medicinal products market is witnessing steady growth and is projected to expand at a compound annual growth rate (CAGR) of 5–8% during the forecast period. This growth ...

Secures long‑term ownership and protection of Link_TSG6, strengthening its global IP position in key markets·         De‑risks development and enhances long‑term value, supporting advancement ...

Spago Nanomedical AB (publ) announced today that the independent Data Monitoring Committee (DMC) of the Tumorad-01 study declared that a primary endpoint, identifying the maximum tolerated dose, has ...

Global Biosimulation Market OverviewThe global biosimulation market is experiencing rapid expansion and is expected to grow at a remarkable compound annual growth rate of 15–20% through 2028. This ...

Symeres appoints Henning Steinhagen as CEO to drive next phase of strategic growth Nijmegen, Netherlands [06.05.2026] – Symeres, a leading transatlantic CRDMO for drug discovery and development, today ...

AES Cleanroom Technology appoints John Groth as Chief Revenue Officer  MONTGOMERYVILLE, Pa. April 27, 2026 - AES Cleanroom Technology, a leading provider of modular cleanroom design, manufacturing, ...

Holista Colltech Limited (ASX: HCT) (Holista or the Company) is pleased to announce that it has entered into a binding Joint Venture Agreement with Swang Chai Chuan Limited (HKEX: 2321) (SCC) for the ...

LUND, SE / ACCESS Newswire / May 6, 2026 / Cantargia AB (publ) (Nasdaq Stockholm:CANTA) will publish the company's interim report for Q1 2026 on Tuesday, May 19, 2026, at 07:00 a.m. CEST.In ...

Vitalant and San Diego  Blood Bank Complete Strategic MergerCombination to expand national network capabilities to Southern California, including cell and gene therapy support, cryopreservation, and ...

A new European research network is accelerating innovations in membrane science that could cut the cost of life-saving cancer treatments, pull CO₂ directly from industrial emissions, and deliver clean ...